肺癌是我国最常见的癌症类型，其发病率和死亡率多年来始终位居恶性肿瘤之首。据广州医科大学附属第一医院呼吸与危重症医学科主任医师周承志近日表示，随着靶向治疗等多种治疗手段的出现，肺癌患者的总体生存时间已得到显著改善。为实现肺癌的“慢病化”，我国正不断推进创新药的医保落地，让更多患者受益。
周承志主任医师指出，肺癌的治疗已进入多元化时代，创新药的应用为患者带来了更多的治疗选择。通过早期筛查、精准诊断和个性化治疗，肺癌患者的生存期和生活质量得到了明显提高。然而，要实现肺癌的“慢病化”，还需进一步提高公众对肺癌防治的认识，加强医患沟通，推动医保政策向创新药的倾斜。
据了解，我国政府已制定了一系列政策措施，推动创新药的研发和应用。其中包括加快新药审批速度、优化医保报销政策等。随着这些政策的落地实施，肺癌患者将更快地用到更多具有疗效的创新药，从而加速肺癌“慢病化”的进程。
Title: Innovation in Medicine Helps Accelerate the “Chronicization” of Lung Cancer
Keywords: Innovation, Lung Cancer, Chronicization
News content:
Lung cancer is the most common type of cancer in China and has maintained the highest incidence and mortality rate among malignant tumors for many years. According to Dr. Zhou Chengzhi, Director of the Respiratory and Critical Care Medicine Department at Guangzhou Medical University Affiliated First Hospital, with the emergence of various treatment methods such as targeted therapy, the overall survival time of lung cancer patients has significantly improved. To achieve the “chronicization” of lung cancer, China is continuously promoting the insurance coverage of innovative drugs, benefiting more patients.
Dr. Zhou pointed out that the treatment of lung cancer has entered a diversified era, and the application of innovative drugs has brought more treatment options for patients. Through early screening, precise diagnosis, and personalized treatment, the survival period and quality of life of lung cancer patients have been significantly improved. However, to achieve the “chronicization” of lung cancer, it is necessary to further enhance the public’s awareness of lung cancer prevention and control, strengthen doctor-patient communication, and promote the policy inclination of insurance reimbursement for innovative drugs.
It is understood that the Chinese government has formulated a series of policy measures to promote the research and application of innovative drugs, including accelerating the approval process of new drugs and optimizing the reimbursement policy of medical insurance. With the implementation of these policies, lung cancer patients will be able to use more effective innovative drugs more quickly, thus accelerating the process of “chronicization” of lung cancer.
【来源】http://www.chinanews.com/life/2024/01-04/10140476.shtml
Views: 1